GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData Read more
AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData Read more
New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China Read more